STAAR Surgical Co
NASDAQ:STAA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
26.14
52.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
STAAR Surgical Co
STAAR Surgical Co
Cash from Operating Activities
STAAR Surgical Co
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
STAAR Surgical Co
NASDAQ:STAA
|
Cash from Operating Activities
$47.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Operating Activities
$85m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash from Operating Activities
$255.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Operating Activities
$522.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Operating Activities
$499.3m
|
CAGR 3-Years
131%
|
CAGR 5-Years
46%
|
CAGR 10-Years
46%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash from Operating Activities
$214.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
24%
|
CAGR 10-Years
16%
|
|
STAAR Surgical Co
Glance View
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.
See Also
What is STAAR Surgical Co's Cash from Operating Activities?
Cash from Operating Activities
47.1m
USD
Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Cash from Operating Activities amounts to 47.1m USD.
What is STAAR Surgical Co's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
21%
The average annual Cash from Operating Activities growth rates for STAAR Surgical Co have been -5% over the past three years , 21% over the past five years .
You don't have any saved screeners yet
